CF101
CF101-241UV
Phase 2 small_molecule terminated
Quick answer
CF101 for Uveitis, Posterior is a Phase 2 program (small_molecule) at Can-Fite BioPharma with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Can-Fite BioPharma
- Indication
- Uveitis, Posterior
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- terminated